The objective of this study was to evaluate, using an embryo donation model, whether impaired oocyte/embryo developmental competence and/or changes in uterine milieu are responsible for the previously observed adverse effects of superovulation with gonadotrophins on implantation and fetal development in mice. Embryos from superovulated and non-stimulated females were transferred to separate uterine horns within the same superovulated or non-stimulated pseudopregnant recipient mice. Embryo development was impaired as a significantly higher proportion of normal embryos from control donors (61%) were blastocysts on transfer day compared with superovulated donors (41%; P ⍧ 0.001). The implantation rate in control recipients was significantly reduced after transfer of embryos from superovulated donors (12%) compared with control donors (25%; P ⍧ 0.001). Uterine receptivity was impaired in superovulated recipients. The implantation rate of control embryos was significantly higher in control (25%) than in superovulated recipients (7%; P ⍧ 0.001). Transfer of embryos recovered from superovulated donors resulted in significantly higher post-implantation fetal mortality in superovulated recipients (69%) than in control recipients (36%; P ⍧ 0.01), and the mean weight of live fetuses was significantly lower for fetuses obtained from superovulated recipients (0.51 g) compared with that of fetuses obtained from control recipients (0.72 g; P ⍧ 0.006). Hence, ovarian stimulation appears to impair oocyte/embryo quality as well as uterine milieu.
Introduction
Although in general it is not possible to extrapolate from animal models to humans, considerable similarities exist among Gonadotrophins are commonly used for superovulation in many mammalian species in the early stages of development animals and in humans, for example to increase the number with respect to morphology and metabolism. This suggests of oocytes that can be retrieved for IVF, thus improving the that information obtained from peri-implantation embryos of overall chance for successful fertilization and pregnancy. laboratory animals might be applicable to those of the human Despite considerable progress in assisted reproduction techno- (Brinster, 1975) . logy in recent years, the pregnancy rate remains low as high
We have reported previously that treatment with gonadotronumbers of transferred embryos fail to implant. Furthermore, phins impairs pre-and post-implantation development in mice. increased incidence of gestational complications such as hyperIncreased pre-and post-implantation mortality, low fetal weight tension, bleeding, placenta praevia and low birth weight, have and fetal growth retardation were observed in superovulated also been reported (Tanbo et al., 1995; Maman et al., 1998) .
mice and in animals treated with ovulation induction alone Exogenous administration of gonadotrophins results in higher (Ertzeid and Storeng, 1992) . Furthermore, delayed implantation concentrations of circulating steroids which may affect oocyte and presumably impaired implantation did occur (Ertzeid et al., and/or embryo quality, oviductal and/or uterine environment 1993) . The objective of this study was to evaluate whether as well as the synchrony that normally exists between the impaired embryo quality and/or changes in uterine milieu are embryo and the endometrium at the time of implantation. responsible for the previously observed adverse effects of Hence, a relationship may exist between ovarian stimulation superovulation with gonadotrophins on implantation and fetal with gonadotrophins and the low implantation rate and the development in mice. Taking advantage of the fact that the gestational complications observed. For obvious ethical uterus in mice has two horns, an embryo donation model was reasons, only minimal, directly derived scientific information used (Storeng and Jonsen, 1984) , in which in-vitro-cultured exists on the impact of ovarian stimulation on embryo developembryos from superovulated and non-stimulated females were ment, implantation and gestation in humans. Therefore, for transferred to separate uterine horns within the same superovulated or non-stimulated pseudopregnant recipient. the majority of such studies, rodents are the preferable model. same control or superovulated recipient (see Figure 1) . Available normal embryos (two to six embryos) were transferred to the uterine horns of females on day 3 of pseudopregnancy. Briefly, the animals were anaesthetized with an i.p. injection of 0.2 ml Dormicum:Hypnorm (midazolam/fentanyl/fluanison; National Hospital Pharmacy, Oslo, Norway). A paralumbar incision was made on the recipient female and each uterine horn was consecutively pulled through the excision. The uterus was punctured with a needle, and through this hole embryos were transferred to the lumen, using a finely drawn glass pipette. Thereafter, the uterus was replaced in the abdominal cavity and the skin incision closed by clips. One recipient received control embryos in the right uterine horn, while embryos from superovulated donors were transferred in the left uterine horn. The next recipient received embryos derived from superovulated donors in the right uterine horn and control embryos in the left uterine horn. Figure 1 . Embryo donation model. In-vitro-cultured embryos from This pattern was followed throughout the experiments in order to superovulated and non-stimulated females were transferred to alleviate any technically induced influence in the outcome of the separate uterine horns within the same superovulated or nonembryo transfer. Seventeen replicate experiments with a total of 182 stimulated pseudopregnant recipient.
embryo transfers to 91 pseudopregnant recipient mice were performed. A total of 820 embryos was transferred as follows: 116 control
Materials and methods
embryos and 340 embryos from superovulated mice to control Animals recipients; 134 control embryos and 230 embryos from superovulated Female C57Bl/6J mice (aged 2-3 months) and male fertile or mice to superovulated recipients. vasectomized B6CBA/F1 mice (aged 3-12 months) were obtained from Bomholtgaard, Denmark for use in these experiments. The
Assessment of implantation and post-implantation development animals were housed under a 12 h light:12 h dark regimen (light on
The recipients were killed on day 18 of gestation and the uterine at 7:00), with a temperature of 23°C and relative humidity of 44%.
contents examined. The number of live fetuses, stillborns and early The mice were fed a standard pellet diet ad libitum, and had free and late resorptions in each uterine horn was recorded. Each fetus access to drinking water.
was examined for macroscopic malformations, and weighed. The implantation rate was calculated as: (total number of liveborns, Gonadotrophin treatment of donor and recipient females stillborns and resorptions/number of embryos transferred). The postPregnant mare's serum gonadotrophin (PMSG) (Folligon; Intervet implantation mortality was calculated as: (number of resorptions and Norge, Oslo, Norway) and human chorionic gonadotrophin (HCG) stillborns/number of implantations). (Profasi; Serono, Geneva, Switzerland) were used. Donor and recipient females for the experiments were chosen without regard to their Statistical analysis oestrous cycle, and were superovulated with an i.p. injection of The data were analysed using Student's t-test for continuous data and 10 IU PMSG in 0.1 ml 0.145 mol/l NaCl at 12:00, followed 48 h χ 2 for categorical data. Differences were considered significant later by an i.p. injection of 10 IU HCG in 0.1 ml 0.145 mol/l NaCl at P Ͻ 0.05. to induce ovulation. Controls were injected with the vehicle at the appropriate times. Donor females were mated with fertile males, and recipients were rendered pseudopregnant by mating with vasectomized
Results

males. The presence of a vaginal plug on the following day indicated
This embryo donation model used to evaluate the impact of successful mating, and this was designated day 1 of gestation. Since ovarian stimulation on embryo quality and/or uterine the presence of a coagulation plug does not necessarily indicate a pregnancy, it was assumed in this study that vaginal plug-positive receptivity, yielded four groups of offspring from: (i) control mice may fail to become pregnant after transfer, due not only to the embryos to control recipients; (ii) embryos from superovulated quality of the embryos and/or endometrium but also to failure to donors to control recipients; (iii) control embryos to superovubecome pseudopregnant. lated recipients; and (iv) embryos from superovulated donors to superovulated recipients.
Embryo recovery and in-vitro culture
Pregnant donor mice were killed by cervical dislocation on gestational Impact of ovarian stimulation on embryo developmental day 2. The oviducts were excised and flushed with M2 medium competence (Sigma Aldrich Norway AS, Oslo, Norway). Morphologically normal day 2 embryos (2-to 4-cell) were pooled after collection, washed Morphological examination of normal embryos transferred on twice in M2 medium and transferred to a 0.05 ml droplet of M16 day 4 revealed that a significantly higher proportion of embryos Medium (Sigma), overlaid with paraffin oil, and incubated at 37°C from control donors had reached the blastocyst stage (61%) in a humidified atmosphere of 5% CO 2 in air for 48 h. At day 4, normal than had those from superovulated donors (41%; P Ͻ 0.001; embryos were pooled and their number and stage of development Table I ).
(compacted morulae, early to fully expanded blastocysts) were Caesarean section on control recipients on gestational day recorded.
18 revealed a significantly reduced implantation rate (12%) after transfer of embryos from superovulated donors than from Embryo transfer controls (25%; P ϭ 0.001; Table II ). There was no difference At day 4, normal embryos from control and superovulated mice were divided randomly and transferred to separate uterine horns within the in post-implantation mortality in control recipients after transfer recipients, post-implantation mortality was increased (69%) compared with that in control recipients (36%; P ϭ 0.01; Table III ). 
Impact of ovarian stimulation on uterine milieu
The objective of this study was to evaluate whether impaired embryo developmental capacity and/or changes in uterine milieu are responsible for the previously observed adverse effects of superovulation with gonadotrophins on implantation The reduced weight of live fetuses after transfer to control b P ϭ 0.01. c P ϭ 0.01.
recipients of embryos from superovulated donors was not statistically significant, but may suggest some negative effect of superovulation even on viable embryos. In previous studies, increased pre-implantation mortality Table IV . Effect of ovarian stimulation on the weight of live fetuses after superovulation has been reported in mice (Beaumont and Smith, 1975; Ertzeid and Storeng, 1992) The causes of the loss of developmental competence of (n ϭ 26) (n ϭ 6) embryos from superovulated donors remain unknown. Chromosomal abnormalities may account for reduced viability of a P ϭ 0.05.
embryos from superovulated females because superovulation b P ϭ 0.006.
has been found to increase the proportion of chromosomal abnormalities in murine embryos (Elbling and Colot, 1985, 1987; Luckett and Mukherjee, 1986) as well as in oocytes in of embryos from control or from superovulated donors (34 versus 36%; Table III) . No difference in mortality was observed rats (Tain et al., 2000) . As ovarian stimulation produces a cascade of hormonal and physiological events, oocytes mature in superovulated recipients after transfer of embryos from control or from superovulated donors (89 versus 69%; Table  in an environment different from that of naturally matured oocytes (Foote and Ellington, 1988) , and variation in the III). The mean weight of live fetuses obtained from control recipients was similar both for fetuses obtained after transfer timing of ovulation may also occur (Allen and McLaren, 1971) . New evidence from molecular biology studies of of embryos from superovulated donors (0.72 g) and for control embryos (0.89 g; P ϭ 0.05; Table IV) .
mammalian oogenesis has implicated a role for gonadotrophins
